Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study 外文参考文献.docVIP

下载本文档

12
0
约4.33万字
约 12页
2017-05-10 发布于上海
举报

Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study 外文参考文献.doc

Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study 外文参考文献

HindawiPublishingCorporation AutoimmuneDiseases Volume2012,ArticleID954739,11pages doi:10.1155/2012/954739 ClinicalStudy RecombinantT-CellReceptorLigand(RTL)forTreatmentof MultipleSclerosis:ADouble-Blind,Placebo-Controlled,Phase1, Dose-EscalationStudy VijayshreeYadav, 1DennisN.Bourdette,1,2JamesD.Bowen,3 SharonG.Lynch, 4 5 6 JackSimon, AndrewGoldstein, AlJ.Ferro, DavidMattson, JanaPreiningerova, ChristopherT.BeverJr., 7 GregoryG.Burrows, 1HalinaOffner,1,2,9 andArthurA.Vandenbark1,2,10,11 2 8 8 1 2 DepartmentofNeurology,OregonHealthScienceUniversity,L226,31

您可能关注的文档

文档评论（0）

1亿VIP精品文档

更多 >

Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study 外文参考文献.docVIP